Gabapentin Use in Older Adults with Neuropathic and Musculoskeletal Pain

1. Indications and Comparative Efficacy

• Neuropathic pain (burning, shooting, electric‑like sensations, allodynia) should be treated first with gabapentin – the American Geriatrics Society lists gabapentin as a first‑line option for neuropathic pain in older adults. [1][2]
• Pure musculoskeletal/joint pain is best managed with topical NSAIDs (e.g., diclofenac, ketoprofen), which have strong evidence for efficacy and a superior safety profile in the elderly. [1][2]
• Post‑surgical leg pain that may contain both nociceptive and neuropathic components can be considered for gabapentin when a neuropathic element is identified. 1

2. Initiation, Dosing, and Titration in Older Adults

• Start at an extremely low dose (100–200 mg per day); for frail patients or those with renal impairment, 100 mg every other day may be used. 1
• Increase the dose by 100–200 mg every 3–7 days, with close monitoring for adverse effects at each step. 1
• Target maintenance dose for most older adults is 300–900 mg per day in divided doses, which is lower than the standard adult range. 1
• Standard adult therapeutic range is 900–3600 mg per day, but elderly patients typically require and tolerate lower doses. 1

3. Safety Profile and Monitoring

• Somnolence occurs in 19–21 % and dizziness in 17–28 % of older patients on gabapentin, markedly increasing fall risk. 1
• Mental clouding and ataxia are reported as “very problematic” in this age group and should prompt dose reassessment. 1
• Fall risk is a major concern, especially in patients with a prior fall requiring surgery; gait and balance should be evaluated regularly. 1
• During titration, assess for somnolence, dizziness, confusion, and ataxia at each dose increase and document any changes. 1
• Evaluate fall risk and gait stability at each follow‑up visit while the patient is on gabapentin. 2

4. Alternative or Adjunctive Therapies (First‑Line Options)

• Topical NSAIDs (e.g., diclofenac gel) provide strong analgesic benefit for musculoskeletal pain with minimal systemic absorption and superior safety in the elderly. [1][2]
• Topical lidocaine has limited efficacy data but is very safe due to low systemic exposure and can be used as an adjunct. 1
• Antidepressants (duloxetine, nortriptyline) are also first‑line for neuropathic pain when a neuropathic component is present. 1

5. Duration of Trial and Discontinuation

• Plan a time‑limited trial of gabapentin for 4–8 weeks; if pain relief is insufficient, discontinue and consider alternative therapies. 2

6. Drug‑Interaction Precautions

• Separate gabapentin administration from antacids containing aluminum or magnesium by at least 2 hours to avoid reduced absorption. 2

*All bullet points are based on cited evidence from the American Geriatrics Society (Journal of the American Geriatrics Society, 2020). Strength of evidence is noted where explicitly described (e.g., “strong evidence” for topical NSAIDs).